about
Strategies and methods to study female-specific cardiovascular health and disease: a guide for clinical scientistsComplications and challenges associated with polycystic ovary syndrome: current perspectivesDecreased cholesterol efflux capacity and atherogenic lipid profile in young women with PCOS.Finding novel molecular connections between developmental processes and disease.Genetic loci associated with coronary artery disease harbor evidence of selection and antagonistic pleiotropyAssociation between polycystic ovary syndrome, oral microbiota and systemic antibody responsesMetabolomics reveals impaired maturation of HDL particles in adolescents with hyperinsulinaemic androgen excess.Association between Polycystic Ovary Syndrome and Gut Microbiota.Sex-Specific Disparities in Risk Factors for Coronary Heart Disease.Cardiovascular Disease and 10-Year Mortality in Postmenopausal Women with Clinical Features of Polycystic Ovary Syndrome.Sex, Gender, and Transgender: Metabolic Impact of Cross Hormone Therapy.Elevated circulating levels of betatrophin are associated with polycystic ovary syndrome.Intradermal administration of endothelin-1 attenuates endothelium-dependent and -independent cutaneous vasodilation via Rho kinase in young adults.Reproductive health, obesity, and cardiometabolic risk factors among Samoan women.The effect of prolactin levels on MPV in women with PCOS.
P2860
Q26749044-DF753128-F3D5-481F-AD06-EF9FDE9E027AQ26799566-0827CD1E-37EB-40E4-9DE6-EC892631935CQ33568979-D8F9B3BE-E7EC-412F-86E6-D691AD40AB24Q33685461-EB5500FA-9395-4BB3-8578-57A843B7FDB9Q33825082-79A5A82A-C404-4EC6-9847-18B6CADE869FQ34215217-23E9FC22-1E5F-47D4-919F-46011BEBC217Q35671062-6BCFF4FE-D2F4-4044-996E-807AFA1F9A9FQ35993883-8CE4A473-37A3-46F2-AE73-85CAEB5AAC6CQ38537278-7D9ED4BB-D28D-4EC6-B49A-96D7FB4FD02FQ40716291-9296B77F-5CDD-47C7-8EAA-9E84869459CBQ46190351-213C4E1F-C526-4D0F-AF25-7D837BAFA165Q50936046-89C7C6B7-522C-4F9E-915D-2DEF2769FA3AQ51307195-1D6BEDBF-937B-4E77-8688-4F9431D540D5Q52583736-4A57B352-FB4B-47CF-9D18-2B39793B3314Q54221910-2825F541-7A18-4902-9991-CF630A84B5D7
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Cardiovascular disease risk in women with PCOS.
@en
Cardiovascular disease risk in women with PCOS.
@nl
type
label
Cardiovascular disease risk in women with PCOS.
@en
Cardiovascular disease risk in women with PCOS.
@nl
prefLabel
Cardiovascular disease risk in women with PCOS.
@en
Cardiovascular disease risk in women with PCOS.
@nl
P1433
P1476
Cardiovascular disease risk in women with PCOS.
@en
P2093
Anuja Dokras
P304
P356
10.1016/J.STEROIDS.2013.04.009
P577
2013-04-26T00:00:00Z